Clinical outcomes of Early-progressed follicular lymphoma in Korea : A multicenter, retrospective analysis
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0004192
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1) Patients histologically diagnosed with follicular lymphoma (ICD-10 C82.0 to C82.9)
2) Radiologically confirmed disease progression within 24 months from the start date of an induction chemotherapy
3) All of the following should be available for retrospective analysis.
- Pathologic findings report
- Medical records containing age, sex, date of diagnosis, clinical symptoms, laboratory findings, treatment methods, progression, survival, death, etc.
Exclusion Criteria
1) Known histologic transformation to aggressive lymphoma
2) Follicular lymphoma grade 3B
3) Patients whose pathologic findings report and appropriate medical records are not available
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival period
- Secondary Outcome Measures
Name Time Method Progression free survival period